The ongoing clinical trial (NCT04678661) aims to investigate effects on glycaemic control, feasibility and usability of a smart pen consisting of a clip-on dose recorder with wireless connection to a ‘My Dose Coach smartphone app’ and provides dosing suggestions for people with T2D on once daily basal insulin. Here, INS is linked to type 2 diabetes mellitus.